Correlation Between Enliven Therapeutics and Spero Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Spero Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Spero Therapeutics.

Diversification Opportunities for Enliven Therapeutics and Spero Therapeutics

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Enliven and Spero is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Spero Therapeutics go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and Spero Therapeutics

Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 1.45 times more return on investment than Spero Therapeutics. However, Enliven Therapeutics is 1.45 times more volatile than Spero Therapeutics. It trades about -0.19 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.28 per unit of risk. If you would invest  2,765  in Enliven Therapeutics on September 3, 2024 and sell it today you would lose (327.00) from holding Enliven Therapeutics or give up 11.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Enliven Therapeutics  vs.  Spero Therapeutics

 Performance 
       Timeline  
Enliven Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Spero Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Enliven Therapeutics and Spero Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enliven Therapeutics and Spero Therapeutics

The main advantage of trading using opposite Enliven Therapeutics and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.
The idea behind Enliven Therapeutics and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account